Evidence map›Paper›PMID 32943651›Full record

ArticleScientific reports2020

Punica granatum L.-derived omega-5 nanoemulsion improves hepatic steatosis in mice fed a high fat diet by increasing fatty acid utilization in hepatocytes.

K Zamora-López, L G Noriega, A Estanes-Hernández, I Escalona-Nández, S Tobón-Cornejo, A R Tovar, V Barbero-Becerra, C Pérez-Monter

2 registry-linked trialsAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05142085 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effect of Nano-PSO in Patients With Parkinson's Disease: Clinical Efficacy and Results in Molecular Imaging.

TypeinterventionalSponsorDistribuidora Biolife SA de CVRan2021 to 2023Enrolled170ConditionsParkinson DiseaseArmsnano-PSO, placebo
NCT06550167 narecruitingnot on this mapstarted 2024, after this paper: background citation

Neuroprotective Effect of Omega (Nano PSO), Changes in Neurotrophic BDNF and VEGF, and Their Association With Cognitive Status in Patients Who Used to Consume Psychoactive Substances

TypeinterventionalSponsorDistribuidora Biolife SA de CVRan2024 to 2027Enrolled80ConditionsAddiction, Drug(S), LSD, NeuroprotectiveArmsNano-PSO, Pomegranate seed oil (omega-5), PLACEBO
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Toxicological Profile of aJournal of toxicology · 2026
    Article
  2. Article
  3. Article
  4. Pomegranate: A review of the heavenly healer's past, present, and future.Iranian journal of basic medical sciences · 2023
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K Zamora-López *Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080, CDMX, México.
L G Noriega *Departamento de Fisiología de La Nutrición, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080 CDMX, México.
A Estanes-HernándezDepartamento de Gastroenterología, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080, CDMX, México.
I Escalona-NándezDepartamento de Gastroenterología, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080, CDMX, México.
S Tobón-CornejoDepartamento de Fisiología de La Nutrición, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080 CDMX, México.
A R TovarDepartamento de Fisiología de La Nutrición, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080 CDMX, México.
V Barbero-BecerraUnidad de Medicina Traslacional, Fundación Clínica Médica Sur, Toriello Guerra, Puente de Piedra 150, Tlalpan, 14050, CDMX, México.
C Pérez-MonterDepartamento de Gastroenterología, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, 14080, CDMX, México. carlos.perezm@incmnsz.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pomegranate seed oil (PSO) is mainly composed of punicic acid (PA), a polyunsaturated fatty acid also known as omega-5 (ω-5), a potent antioxidant associated with a variety of metabolic and cellular beneficial effects. However, the potential benefits of a nanoemulsified version of ω-5 (PSOn) have not been evaluated in a pathological liver condition. Here, we examined whether PSOn had beneficial effects on C57BL/6N mice fed a high-fat diet (HFD), specifically on hepatic steatosis. We observed that PSOn supplementation decreased body weight and body fat mass in control mice, whereas glucose intolerance, insulin resistance, energy expenditure, and hepatic steatosis were improved in both control mice and in mice fed a HFD. Interestingly, PSOn increased fatty acid oxidation in primary hepatocytes and antioxidant gene expression. Altogether, our data indicate that PSOn effectively reduces some of the HFD-derived metabolic syndrome indicators by means of an increase in fatty acid oxidation within hepatocytes.

Indexed as

AnimalsAntioxidantsDiet, High-FatEmulsionsEnergy MetabolismFatty AcidsFatty Acids, UnsaturatedGlucose IntoleranceHepatocytesInsulin ResistanceLinolenic AcidsMaleMiceMice, Inbred C57BLNon-alcoholic Fatty Liver DiseaseOxidation-ReductionAntioxidantsEmulsionsFatty AcidsFatty Acids, UnsaturatedLinolenic AcidsPlant Oilspunicic acid

Identifiers

PMID32943651
PMCPMC7499212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.